Chemotherapy without radiation therapy as initial treatment for primary CNS lymphoma in older patients

Neurology

Volumn 46, Issue 2, 1996, Pages 435-439

  Freilich, Ronnie J ^a   Delattre, Jean Yves ^b   Monjour, Annick ^c   DeAngelis, Lisa M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c Pasteur Hospital   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CORTICOSTEROID; CYTARABINE; METHOTREXATE; PROCARBAZINE; THIOTEPA; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM TUMOR; CLINICAL ARTICLE; COGNITIVE DEFECT; EYE TUMOR; FEMALE; HUMAN; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKOENCEPHALOPATHY; LYMPHOMA; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0029881217     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.46.2.435     Document Type: Article

References (19)

1. Eby NL, Grufferman S, Flannelly CM, Schold SC Jr, Vogel FS, Burger PC. Increasing incidence of primary brain lymphoma in the US. Cancer 1988;62:2461-2465.
2. Miller DC, Hochberg FH, Harris NL, Gruber ML, Louis DN, Cohen H. Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma. The Massachusetts General Hospital experience 1958-1989. Cancer 1994; 74:1383-1397.
3. Henry JM, Heffner RR Jr, Dillard SH, Earle KM, Davis RL. Primary malignant lymphomas of the central nervous system. Cancer 1974;34:1293-1302.
4. Loeffler JS, Ervin TJ, Mauch P, et al. Primary lymphomas of the central nervous system: patterns of failure and factors that influence survival. J Clin Oncol 1985;3:490-494.
5. Murray K, Kun L, Cox J. Primary malignant lymphoma of the central nervous system. Results of treatment of 11 cases and review of the literature. J Neurosurg 1986;65:600-607.
6. Nelson DF, Martz KL, Bonner H, et al. Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315. Int J Radiat Oncol Biol Phys 1992;23:9-17.
7. Neuwelt EA, Goldman DL, Dahlborg SA, et al. Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function. J Clin Oncol 1991;9:1580-1590.
8. DeAngelis LM, Yahalom J, Thaler HT, Kher U. Combined modality therapy for primary CNS lymphoma. J Clin Oncol 1992;10:635-643.
9. DeAngelis LM, Delattre JY, Posner JB. Radiation-induced dementia in patients cured of brain metastases. Neurology 1989; 39:789-796.
10. Schultz C, Scott C, Wasserman T, et al. Pre-irradiation chemotherapy (CTX) with cytoxan, adriamycin, vincristine, and decadron (CHOD) for primary central nervous system lymphomas (PCNSL): initial report of Radiation Therapy Oncology Group (RTOG) protocol 88-06 [abstract]. Proc Am Soc Clin Oncol 1994; 13:174.
11. Kawakami Y, Tabuchi K, Ohnishi R, Asari S, Nishimoto A. Primary central nervous system lymphoma. J Neurosurg 1985;62:522-527.
12. Cohen IJ, Vogel R, Matz S, et al. Successful non-neurotoxic therapy (without radiation) of a multifocal primary brain lymphoma with a methotrexate, vincristine, and BCNU protocol (DEMOB). Cancer 1986;57:6-11.
13. McLaughlin P, Velasquez WS, Redman JR, et al. Chemotherapy with dexamethasone, high-dose cytarabine, and cisplatin for parenchymal brain lymphoma. J Natl Cancer Inst 1988; 80:1408-1412.
14. Boiardi A, Silvani A, Valentini S, Salmaggi A, Allegranza A, Broggi G. Chemotherapy as first treatment for primary malignant non-Hodgkin's lymphoma of the central nervous system: preliminary data. J Neurol 1993;241:96-100.
15. Glass J, Gruber ML, Cher L, Hochberg FH. Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcome. J Neurosurg 1994;81: 188-195.
16. Margolis L, Fraer R, Lichter A, Char DH. The role of radiation therapy in the management of ocular reticulum cell sarcoma. Cancer 1980;45:688-692.
17. Strauchen JA, Dalton J, Friedman AH. Chemotherapy in the management of intraocular lymphoma. Cancer 1989;63:1918-1921.
18. Peterson K, Gordon KB, Heinemann M-H, DeAngelis LM. The clinical spectrum of ocular lymphoma. Cancer 1993;72:843-849.
19. DeAngelis LM, Yahalom J, Rosenblum M, Posner JB. Primary CNS lymphoma: managing patients with spontaneous and AIDS-related disease. Oncology 1987;1:52-59.